The markets opened flat with the Dow easing 2 points to 16,904 even as jobless claims fell more than expected. Nasdaq slipped 5 points to 4,357.
On the upside
BlackBerry (Nasdaq: BBRY) reversed year ago losses to post an unexpected profit for the first quarter.
StemCells (Nasdaq: STEM) reported positive interim data from a PhaseI/II clinical trial of its age-related macular degeneration treatment HuCNS-SC.
On the downside
KBR (NYSE: KBR) fell to an unexpected loss for the first quarter and will conduct a strategic review.
Pier 1 Imports (NYSE: PIR) disappointed with lower first quarter earnings that missed expectations and cut its full year earnings forecast.
MD Anderson Cancer Center criticized Northwest Biotherapeutics (NYSE: NWBO) for issuing press releases containing unjustified claims about its cancer vaccine DCVax-Direct.
In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE while decliners edged out advancers by nearly 5 to 4 on Nasdaq. The broader S&P 500 held steady at 1956. Bitcoin eased $0.94 or 0.16% to $602.50.